Julie Rosenberg
Julie Rosenberg, DrPH, MPH, is Associate Director, Better Evidence at Ariadne Labs, a program working to help current and future health care providers access the latest clinical knowledge at the front lines of care delivery through digital tools. With the Director, she has led the scale-up strategy, research and program operations, leveraging more than $40M of in-kind donations annually, to maximize the impact of the program on patient outcomes.
Julie is also Deputy Director of the Global Health Delivery Project at Harvard where she supports health care providers by studying what works in health care delivery and sharing those lessons through courseware and training. Julie has helped lead the development of 45+ open-access teaching cases published through Harvard Business Publishing and supported the development of an online community of practice engaging 25,000+ global health providers for over a decade.
Previously, Julie worked in clinical research at Emory University School of Medicine and in community-based nonprofit organizations in Latin America and the US. Julie attained her DrPh in public health leadership from Georgia Southern University, her MPH in epidemiology and global health from the Rollins School of Public Health at Emory University, and a BA in anthropology, with pre-med coursework and a Spanish language certificate, from Harvard College.
Julie Rosenberg, MPH, in Romper on the challenges for parents to get COVID vaccines for infants and toddlers and the continued need for advocacy and resources to broaden access.
The Harvard T.H. Chan School of Public Health highlights the Global Health Delivery Intensive program as it enrolls its 15th annual session.
Julie Rosenberg joins The World to discuss the challenge and importance of vaccine equity.
Julie Rosenberg in US News & World Report on the challenges to expanding primary care’s role in the vaccination effort.
Julie Rosenberg and Dr. Rebecca Weintraub and colleagues from The Commonwealth Fund co-author opinion piece on how pediatricians will be key to vaccinating young children against COVID-19 when they become eligible.
By Laura Subramanian, Anthony McDonnell, Robert Van Exan, Julie Rosenberg, Prashant Yadav, and Rebecca Weintraub As the world awaits the results of COVID-19 vaccine clinical trials, we need to invest now in systems to ensure equitable global vaccine delivery. Sixteen vaccine experts from the vaccine industry, academic and regulatory agencies interviewed by the Center for… Continue reading Vaccine experts speak out on COVID-19 vaccines and how to prepare
New research from our Better Evidence Champions program on medical librarians role in Evidence-Based Medical Practice in Africa.
Our Better Evidence team in BMJ Global Health on finding that the data on the current medical school landscape in Africa was outdated, incomplete and needing updating. Their research identified 444 medical schools in Africa, a 160+% increase from the previous estimate of 169 schools in 2010.
Published in the American Journal of Public Health, Ariadne Labs, together with Boston Children’s Hospital and Google, share lessons learned from the Vaccine Equity Planner and how the tool can identify “vaccine deserts” and support decision makers.
Our Better Evidence team published in BMJ Open on the barriers and facilitators of UpToDate use in resource-limited settings.
Our Better Evidence team published in JMIR Formative Research on the analysis of clickstream data from UpToDate users in resource-limited settings.